Mangalam Drugs and Organics Ltd

₹ 99.4 -1.83%

06 May - close price

mangalamdrugs.com BSE: 532637 NSE : MANGALAM

About

Incorporated in 1977, Mangalam Drugs
& Organics Ltd manufactures Active Pharmaceutical Ingredients and
Intermediates^[1]

Key Points

Business Overview:^[1]
Company manufactures bulk drugs, organic and inorganic chemicals. It is among the few companies which are World Health Organization -approved Indian companies to be associated with the William J Clinton Foundation for manufacture of anti-malarial drugs. Company supplies artemisinin-based bulk drugs to pharmaceutical companies, for manufacturing anti-malarial formulations

Website BSE NSE

Market Cap ₹ 158 Cr.
Current Price ₹ 99.4
High / Low ₹ 132 / 85.2
Stock P/E
Book Value ₹
Dividend Yield 0.00 %
ROCE %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2023
	97.34
	90.36
Operating Profit	6.98
OPM %	7.17%
	-0.00
Interest	3.31
Depreciation	3.63
Profit before tax	0.04
Tax %	-1,150.00%
	0.50
EPS in Rs	0.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Dividend Payout %

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Stock Price CAGR
10 Years:	35%
5 Years:	15%
3 Years:	-9%
1 Year:	-12%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone


Equity Capital
Reserves
Preference Capital


Total Liabilities

CWIP
Investments

Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone





Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone


Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

6 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	50.53%	50.53%	50.53%	50.53%	50.42%	50.41%	50.31%	50.31%	50.31%	50.31%	50.31%	50.31%
	0.00%	0.00%	0.00%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.26%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	49.46%	49.46%	49.46%	49.36%	49.47%	49.49%	49.58%	49.59%	49.58%	49.59%	49.59%	49.42%
No. of Shareholders	21,827	21,071	20,668	20,084	18,988	18,483	17,911	17,943	17,890	17,978	18,610	19,173

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	50.76%	50.76%	49.27%	50.53%	50.53%	50.53%	50.31%	50.31%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.10%	0.26%
	0.19%	0.25%	1.29%	0.01%	0.01%	0.01%	0.00%	0.00%
	49.05%	48.99%	49.44%	49.46%	49.46%	49.36%	49.59%	49.42%
No. of Shareholders	15,529	18,113	19,611	17,884	20,520	20,084	17,943	19,173

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls